Skip to content

Clinical trials

Coronary Disease trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Country / region: Russia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20082
20093
20111
20123
20151
20161
20171
20192
20204
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status3
Enrolling by invitation1
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bakulev Scientific Center of Cardiovascular Surgery2
GlaxoSmithKline2
Sanofi2
Amarin Pharma Inc.1
Amgen1
AstraZeneca1
Boehringer Ingelheim1
Boston Medical Center1
Center for Strategic Planning, of the Federal Medical and Biological Agency1
Eurasian Association of Therapists1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease23
Cardiovascular Diseases7
Coronary Artery Disease6
Heart Diseases6
Atherosclerosis4
Acute Coronary Syndrome3
Diabetes Mellitus3
Dyslipidemias3
Myocardial Ischemia3
Pulmonary Disease, Chronic Obstructive3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.